A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both

Clinical trial NCT05260021 · COMPLETED

Trial details

NCT number: NCT05260021
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 T2D T2DM (Type 2 Diabetes Mellitus)Glucose Metabolism Disorders Endocrine System Diseases Metabolic Disease

Start date: 2022-04-13
Primary completion: 2024-07-30
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.